FHIR IG analytics

Resources that use this resource

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "CodeSystem",
  "id": "kepi-antigen",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen",
  "version": "0.1.0",
  "name": "SGHIKEPIAntigenCodeSystem",
  "title": "SGHI KEPI Antigen",
  "status": "active",
  "date": "2026-09-30T09:16:00+00:00",
  "publisher": "Kathurima Kimathi",
  "contact": [
    {
      "name": "Kathurima Kimathi",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.linkedin.com/in/kathurima-kimathi/"
        },
        {
          "system": "email",
          "value": "kathurimakimathi415@gmail.com"
        }
      ]
    },
    {
      "name": "Oscar John",
      "telecom": [
        {
          "system": "email",
          "value": "oscarjohnotieno@gmail.com",
          "use": "work"
        }
      ]
    },
    {
      "name": "Kennedy Omondi",
      "telecom": [
        {
          "system": "email",
          "value": "kennankole@gmail.com",
          "use": "work"
        }
      ]
    }
  ],
  "description": "Antigens administered under the Kenya Expanded Programme on Immunisation, as recorded on the MOH 510 Immunisation Permanent Register. One concept per antigen: the dose within a series is carried separately on Immunization.protocolApplied.doseNumber, which is what keeps IPV distinct from bivalent OPV and separates the three pentavalent doses. Pending a mapping to CVX or the national antigen list.",
  "content": "complete",
  "count": 8,
  "concept": [
    {
      "code": "bcg",
      "display": "BCG",
      "definition": "Bacille Calmette-Guerin vaccine, given at birth against tuberculosis."
    },
    {
      "code": "bopv",
      "display": "Bivalent oral poliovirus vaccine",
      "definition": "Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks."
    },
    {
      "code": "ipv",
      "display": "Inactivated poliovirus vaccine",
      "definition": "Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them."
    },
    {
      "code": "penta",
      "display": "DTP-HepB-Hib (pentavalent) vaccine",
      "definition": "Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks."
    },
    {
      "code": "pcv10",
      "display": "Pneumococcal conjugate vaccine (PCV10)",
      "definition": "Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks."
    },
    {
      "code": "rota",
      "display": "Rotavirus vaccine",
      "definition": "Oral rotavirus vaccine, given at 6 and 10 weeks."
    },
    {
      "code": "mr",
      "display": "Measles-rubella vaccine",
      "definition": "Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years."
    },
    {
      "code": "yf",
      "display": "Yellow fever vaccine",
      "definition": "Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone."
    }
  ]
}